DK131465B - Analogous process for the preparation of pyrimidinone compounds. - Google Patents

Analogous process for the preparation of pyrimidinone compounds.

Info

Publication number
DK131465B
DK131465B DK510072AA DK510072A DK131465B DK 131465 B DK131465 B DK 131465B DK 510072A A DK510072A A DK 510072AA DK 510072 A DK510072 A DK 510072A DK 131465 B DK131465 B DK 131465B
Authority
DK
Denmark
Prior art keywords
preparation
analogous process
pyrimidinone compounds
pyrimidinone
compounds
Prior art date
Application number
DK510072AA
Other languages
Danish (da)
Other versions
DK131465C (en
Inventor
C A Lipinski
J G Stam
G G Deangelis
H-J E Hess
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to DK294974A priority Critical patent/DK134016B/en
Publication of DK131465B publication Critical patent/DK131465B/en
Application granted granted Critical
Publication of DK131465C publication Critical patent/DK131465C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK510072AA 1971-10-29 1972-10-16 Analogous process for the preparation of pyrimidinone compounds. DK131465B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK294974A DK134016B (en) 1971-10-29 1974-05-31 Analogous process for the preparation of hydroxypyrimidine compounds.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19400671A 1971-10-29 1971-10-29

Publications (2)

Publication Number Publication Date
DK131465B true DK131465B (en) 1975-07-21
DK131465C DK131465C (en) 1975-12-08

Family

ID=22715935

Family Applications (1)

Application Number Title Priority Date Filing Date
DK510072AA DK131465B (en) 1971-10-29 1972-10-16 Analogous process for the preparation of pyrimidinone compounds.

Country Status (25)

Country Link
JP (2) JPS5337870B2 (en)
AR (2) AR198798A1 (en)
AT (2) AT321308B (en)
AU (1) AU467600B2 (en)
BE (1) BE790125A (en)
CA (1) CA980778A (en)
CH (2) CH555832A (en)
DE (3) DE2248741C3 (en)
DK (1) DK131465B (en)
EG (1) EG11013A (en)
ES (2) ES407730A1 (en)
FI (1) FI55503C (en)
FR (1) FR2157865B1 (en)
GB (2) GB1377308A (en)
IE (1) IE37043B1 (en)
IL (2) IL40458A (en)
LU (1) LU66304A1 (en)
NL (1) NL166470C (en)
NO (1) NO136574C (en)
PH (2) PH10129A (en)
PL (2) PL89852B1 (en)
SE (2) SE393376B (en)
SU (2) SU498908A3 (en)
YU (2) YU35125B (en)
ZA (1) ZA727362B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151912U (en) * 1979-04-17 1980-11-01
JPS5752409Y2 (en) * 1979-11-05 1982-11-15
DE3222914A1 (en) * 1982-06-18 1983-12-22 Beiersdorf Ag, 2000 Hamburg SUBSTITUTED 5-PHENYLTHIO-6-AMINO-PYRIMIDINONE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE, AND PREPARATIONS CONTAINING THESE COMPOUNDS
JPH0655686B2 (en) * 1988-08-30 1994-07-27 宇部興産株式会社 Process for producing p-bromophenoxyacetaldehyde dialkyl acetals
KR101452518B1 (en) 2005-08-22 2014-10-21 멜리어 파마슈티칼스 아이, 인코포레이티드 Methods and formulations for modulating lyn kinase activity and treating related disorders
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011150300A1 (en) 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prevention of pancreatic beta cell degeneration
CN110785170B (en) 2017-04-10 2023-03-28 梅里奥尔医药I公司 Treatment of adipocytes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913462A (en) * 1959-11-17 Eahl h
GB951432A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
PL84634B1 (en) 1976-04-30
DE2264374C3 (en) 1981-07-23
IL40458A (en) 1976-05-31
FI55503B (en) 1979-04-30
DE2264374B2 (en) 1980-08-07
DE2248741B2 (en) 1974-11-14
NL166470C (en) 1981-08-17
ZA727362B (en) 1973-11-28
SE7505279L (en) 1975-05-06
NO136574C (en) 1977-09-28
DE2248741C3 (en) 1975-06-26
CH555832A (en) 1974-11-15
JPS5422995B2 (en) 1979-08-10
FI55503C (en) 1979-08-10
LU66304A1 (en) 1973-05-03
IL48790A (en) 1976-05-31
SE397090B (en) 1977-10-17
AU467600B2 (en) 1975-12-04
JPS5337870B2 (en) 1978-10-12
NL7213959A (en) 1973-05-02
SU498908A3 (en) 1976-01-05
DK131465C (en) 1975-12-08
PH10129A (en) 1976-09-02
SU505362A3 (en) 1976-02-28
DE2264657A1 (en) 1974-06-20
YU36295B (en) 1982-06-18
FR2157865A1 (en) 1973-06-08
DE2248741A1 (en) 1973-05-03
IE37043L (en) 1973-04-29
BE790125A (en) 1973-04-16
PH11594A (en) 1978-03-31
IE37043B1 (en) 1977-04-27
JPS53116386A (en) 1978-10-11
AT321308B (en) 1975-03-25
SE393376B (en) 1977-05-09
YU35125B (en) 1980-09-25
AR198798A1 (en) 1974-07-24
DE2264657C2 (en) 1982-09-16
AT320656B (en) 1975-02-25
IL40458A0 (en) 1972-11-28
AR196263A1 (en) 1973-12-10
CH549579A (en) 1974-05-31
NO136574B (en) 1977-06-20
YU255172A (en) 1980-03-15
DE2264374A1 (en) 1973-05-24
AU4722872A (en) 1974-04-04
PL89852B1 (en) 1976-12-31
FR2157865B1 (en) 1975-10-31
ES436624A1 (en) 1977-02-01
GB1377308A (en) 1974-12-11
CA980778A (en) 1975-12-30
YU99179A (en) 1981-08-31
EG11013A (en) 1976-11-30
NL166470B (en) 1981-03-16
ES407730A1 (en) 1976-01-16
IL48790A0 (en) 1976-03-31
GB1377720A (en) 1974-12-18
JPS4852780A (en) 1973-07-24

Similar Documents

Publication Publication Date Title
DK138419B (en) Process for the preparation of 1alpha-hydroxycholecalciferol.
DK134316B (en) Process for the preparation of methyl substituted cuinones.
DK136981B (en) Analogous process for the preparation of basic substituted benzylphthalazone derivatives.
DK129987B (en) Analogous process for the preparation of guanidines.
DK129339B (en) Analogous process for the preparation of N-aminophenylamidines.
DK135799B (en) Process for the preparation of ethambutol.
DK127119B (en) Analogous process for the preparation of 6-amino-9-benzylpurine compounds.
DK131465B (en) Analogous process for the preparation of pyrimidinone compounds.
DK130212B (en) Analogous process for the preparation of 7-aminoindazole derivatives.
DK139030B (en) Process for the preparation of bicyclic pyrimidine derivatives.
DK133470B (en) Process for the preparation of 3alpha-hydroxy-5alpha-steroids.
DK138229B (en) Process for the preparation of (+) (-) - eburnamonine.
DK126998B (en) Analogous process for the preparation of amino-s-triazolylbenzenesulfonamide compounds.
DK133464B (en) Analogous process for the preparation of nitrosourine derivatives.
DK129794B (en) Analogous process for the preparation of N-acyl-3- (piperazinoethyl) -pyrazoles.
DK126780B (en) Process for the preparation of flavone-7-oxyacetates.
DK133902B (en) Process for the preparation of Cephalosporin C.
DK129453B (en) Analogous process for the preparation of 1-aminoisoquinolines.
DK130987B (en) Analogous process for the preparation of 15alpha, 16alpha-methylene-4-androsten-3-ones.
DK133809B (en) Analogous process for the preparation of heterocyclic compounds.
DK139871B (en) Analogous process for the preparation of 3-isonicotinoyl-benzofuran derivatives.
DK139583B (en) Analogous process for the preparation of penicillins.
DK132223B (en) Analogous process for the preparation of benzenesulfonamidopyrimidines.
DK125788B (en) Process for the preparation of p-nitrophenols.
DK136977B (en) Analogous process for the preparation of 6- (alpha-aminobenzyl-alpha-penicilloylamino) -caproic acid.

Legal Events

Date Code Title Description
PBP Patent lapsed